Hello and good evening. I am writing to you as a long

New Post Public Reply Private Reply Replies (1) Message Board
avboy

Hello and good evening. I am writing to you as a long term investor in CEN-Biotech (ticker FITX), and in full support of the company. I would like to give some historical background and investor perspective. I would sincerely appreciate if you would spend the time to read it, and pass it on to the investigation team.

I initially invested in this company in April 2011 when they announced they would be entering the sports nutrition supplement industry (an interest of mine). Creative Edge Nutrition initially reverse merged into a defunct company (ticker LBGE) in 2011 in order to be able to expedite the process of becoming public and bring products to market. The initial CEO of Creative Edge Nutrition (Paul Thomas) announced a product they were going to formulate called Metabolic Xtreme. It was more of a concept and he was slow in moving it forward, and never actually did.

Creative Edge Nutrition subsequently brought in Bill Chaaban to replace him in April 2012 as the new CEO. Shortly after becoming CEO, Bill Chaaban announced milestones and goals over the next couple years in terms of bringing these sports nutrition products to market. He was starting from scratch. However, not only did he bring Metabolic Xtreme to market, but he quickly brought several other products through research and development and to market, including AminoPlex and HyperInfusion. I still use the AminoPlex nutritional products almost daily, and they are great.

Mr. Chaaban also wanted to get a ticker change to reflect the current business that had nothing to do with the old business, so he had it changed from LBGE to FITX. Not only did he get the nutritional side of the company up and running strongly (which is still ongoing), he announced and began development of the medical marijuana subsidiary (CEN-Biotech) in 3/2013. Given the goals announced for the nutritional side, all of which were followed through on over the next couple years, I knew that Mr. Chaaban had integrity and was goal-driven. So, I knew he would work diligently no differently with the CEN-Biotech subsidiary, which he did from the beginning and has continued to do.

Similarly to how he announced goals and plans for the nutritional side of the company, and followed through on every one of them, he also announced goals and plans for the newly formed subsidiary CEN-Biotech. As investors, we again began to see steady progress from the build out of the facility (following full approvals from the Town of Lakeshore, as well as receiving a Ready to Build letter from Health Canada), industry networking, and other tangible progress, everything continued to appear on track. Bill Chaaban recruited an absolutely amazing board of directors (BOD) and medical team consisting of expert physician-scientists with world-renowned recognition in the medical, scientific, research, and financial industries including a prior senior level executive at Fidelity and JPMorgan (see highlighted links below), as well as John Germinario, who works with the US SEC (securities exchange commission). The magnitude and achievements of this personnel would not be joining just any company if the company was not legitimate.

Everything continued to be on track and correlated accurately with every announcement made. Then, we began to run into delays which were due to Health Canada taking much longer than expected for coming to inspect our facility. These delays were months and months despite the company being ready for inspection. When they finally did come to inspect many months later, the report stated that approval was recommended pending the correction of 2 minor issues (a screen over a vent, and the security camera angle). Again, we began to wait many more months for final approval, even though these minor issues were quickly fixed.

In these months of delay, the Town of Lakeshore began to change their stance. They initially welcomed the company to Lakeshore in a public video http://vimeo.com/83685127

and had received approvals for their facility build-out. However, in more recent months while the delays due to Health Canada were occurring, they also decided to try to change the local bylaws and change the zoning in a way which would inhibit CEN-Biotech from operating. A few nearby residents began to complain about the project with outlandish claims/concerns just as license was coming, despite watching the buildings go up and saying nothing for all of the preceding months. It later came out in a letter by the company to the town councilors that the few neighbors were attempting to extort significant compensation in monetary value and employment in return for their support of the company/building, which the company did not stand for (and rightfully so).

These few neighbors were able to influence their local councilors to attempt to write a new bylaw stating medical cannabis grow-ops need to be zoned industrial, not agricultural (CEN-Bio is agricultural). The mayor also began to flip-flop regarding CEN-Bio, suspected to be politically driven. There have been identical zoning motions passed by other towns that were struck down by the provincial government, saying that grow-ops do not require industrial zoning. The town clearly knew what was being built the whole time, provided building permits, along with the ready to build letter from Health Canada. There was a letter written from these few residents and their attorney to Health Canada as well asking them to delay/avoid license to CEN-Biotech, which added more delay.

Along with the delay from the above issues, we began to see an assault against CEN-Biotech by the media. In particular, Grant Robertson of the Globe and Mail has targeted CEN-Biotech with continuous assault of articles, many of which have not been based on true facts, and twisting of the actual facts. I have watched his articles timed with every time that the stock has a continued uptrend. He will release several articles in a row which causes the stock to drop significantly. I have watched this occur over and over. I honestly feel that he has an agenda against the company, whether it is being funded by trader groups, or competition, or something else. I sincerely hope that he is investigated in this as well, because he is a central piece. Matt Finston and Chris Parry are two bloggers who have also been relentlessly attacking CEN-Biotech during all of the delays they have suffered, driving share price further down. In fact, Grant Roberston has quoted and discussed Matt Finston several times in his articles, and I wouldn't be surprised if these individuals were all working together somehow. I truly hope this investigation is fair and they are all investigated. Matt Finston has also talked about shorting FITX on his Twitter and there are shareholders who have all of these screenshots saved.

There is documentation of Libby Davies meeting with the Tilray lobbyists, and later on Libby was quoted in one of Grant Robertson's bash articles on CEN-Biotech, also attacking the company. I hope that paper and money trails are evaluated with these individuals. The prior CEO of Tweed was also bashing FITX on his Twitter. I feel there is an orchestrated attach against the company, likely from competitors who feel threatened by CEN-Biotech since they would be the largest grower upon licensure, and possibly from trading groups who could be shorting the stock. This is just speculation, but I wouldn't at all be surprised as I have watched everything closely unfold since the beginning. These misleading articles, blogs, and events have influenced Health Canada negatively, which led to license denial for CEN-Biotech.

Please read through this page on the CEN-Biotech website, which addresses many of these issues and investor concerns:
http://www.cenbiotechinc.com/PlatformApps/CEN/c1/faq.html


Never once did I feel misled in anyway by any announcements or public releases. There are over 2100 investors on a dedicated CEN-Biotech investor page on the internet alone who feel the same way, which is why we have stuck it out continuously. We have lost significant value in our investments. This is not because of Bill Chaaban, any statements he has made, or any announcements by the company. These losses are purely due to the events, agendas, and manipulation discussed above, which have erroneously influenced Health Canada. CEN-Biotech has been painted in a very unfair light in the media. As one of many investors, I'm sick of watching it happen with no repercussions against these individuals (such as Grant Robertson, Mayor Tom Bain and councillors, local neighbors in Lakeshore, Matt Finston, and Chris Parry). The only investigation that should be ongoing in my opinion is against Grant Robertson, these aforementioned individuals, the Town of Lakeshore, and Health Canada, rather than the company itself. I sincerely hope that your team will quickly find this to be the case.

For those with disabling neurologic diseases (I changed this line slightly for privacy reasons), it is an absolute shame how much of a delay the company has sustained in beginning their research and development of medical cannabis strains and medications, all due to the influence from misleading articles and manipulative behaviors above, as well as unjust retroactive changes in bylaws that the town of Lakeshore has been attempting to pass. I continued to stay invested in CEN-Biotech because I was excited (and still am) with their plans for moving the science of medical cannabis forward, along with the outstanding medical professionals they had collected on their Board of Directors who would be involved in the research and company. It is honestly quite sad for the patients who need better quality medications, which CEN-Biotech has been waiting to begin production of, only to continue being delayed for unjust reasons as discussed above.

I implore you to please investigate fairly, and please investigate the entities mentioned above who have played the biggest role in loss of shareholder value. I have watched this company unfold from the beginning. I have watched Bill Chaaban attain the company's stated goals until the above issues halted the company's progress. I only hope that these issues will be brought to light and the company is cleared and able to continue with their previously stated goals for the future.

Sincerely,
XXX






.



Unlike · Comment
.






You and 53 others like this.
.








View previous comments
..










Michael Peterman Is there a cliff notes version lol.

Yesterday at 12:51pm · Like · 1

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Galleon Forge Two Puts Europe on the AI Map

Updated Category News Views 57

Dublin Hosts Europe's AI Sovereignty Leap If they ever told you Europe was playing catch-up in the high-tech race, someone missed the boat. Armada and Johnson Controls just put Europe right on the AI map. They're cranking up production at Galleon Forge Two in Dublin. Now we're talking about a sovereign AI infrastructure, not that rent-a-cloud deal that's been dangling...

Continue Reading
Gilat's Revenue Dip Spurs Legal Scrutiny for Investors

Updated Category News Views 51

Gilat Satellite's Surprise Revenue Shortfall If anybody thought the satellite business was all about science fiction-esque technology, here's a reality check: when earnings don't meet expectations, shareholders get jittery. This seems to be exactly what's happening with Gilat Satellite Networks Ltd. (NASDAQ: GILT). After twice reaffirming their fiscal 2026 revenue...

Continue Reading
PMET's High-Stakes Call on Shaakichiuwaanaan Update

Updated Category News Views 97

Inside PMET Resources' Critical Investor Briefing Now, this is the kind of investor chatter that cuts to the core of PMET's game plan. We're talking the big guns coming out with PMET Resources (TSX: PMET) as they gear up for what's poised to be a tell-all investor teleconference about their Shaakichiuwaanaan Project. Yep, mark your calendars because on Tuesday, November...

Continue Reading
Brent Crude's Tumult: Oil Giants Weather Market Shifts

Updated Category News Views 21

Oil Market Faces Uncertain Waves The energy sector's a rough sea these days, with Brent crude prices yo-yoing close to that $100 mark. If you're looking for clarity, don't hold your breath—the EIA's latest report suggests we’re sticking near this price for the foreseeable future before easing into more palatable waters come late 2027. But we ain't there yet, as U.S....

Continue Reading
Day Out Snacks Brings Back Sold-Out Peppermint Bark

Updated Category News Views 59

Spicing Up the Holidays with a Best-Seller Return You've got to love when a brand nails it in the holiday treat department, and Day Out Snacks is playing a winning hand by bringing back their Peppermint Bark protein balls. Here we are again, one year after they flew off the shelves like Santa spotted on Christmas Eve. And let me tell you, this re-release has the potential...

Continue Reading
Ares Management Faces Fintech with $691B Assets

Updated Category News Views 100

Anticipation Builds: Ares Awaits TD Cowen Spotlight Ah, Ares Management, the Wall Street heavyweight clocking a colossal $691 billion in assets. Now, they’re angling to dish out some strategic insights. With the TD Cowen 2026 Financials & Fintech Conference set to roll on November 18, what’s better than watching these investment titans take the stage with their CFO...

Continue Reading
Third Lake Parts Ways with WaterView Retail Center

Updated Category News Views 104

Third Lake Partners Exits WaterView Retail in Florida Alright, you don't stumble across deals like this every day. Third Lake Partners just tossed the keys to their WaterView Retail Center in St. Petersburg, wrapping up the retail and residential parts under one roof with Walton Street Capital. It only took a cool five years since its completion in 2021, but hey, better...

Continue Reading
Alyssa Bunch: Big Moves in Tennessee Real Estate

Updated Category News Views 177

Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...

Continue Reading
WZC Networking Celebrates Two Decades of Growth

Updated Category News Views 16

From Humble Beginnings to Industry Authority No one ever started a business thinking it would last two decades without at least a bit of grit and determination. Back in 2006, John Wierzgac decided to leap into the unknown with WZC Networking. It all began with three stalwart customers and a single engineering brain powered by resolve. John's motivation stemmed from...

Continue Reading
Southfield Capital Exits TFS to AEA Investors

Updated Category News Views 123

A Breakthrough Carve-Out Success Story A story that starts with a carve-out and winds up with a strategic sale reeks of experience, and that's precisely what Southfield Capital did with TFS. Back in 2024, they snagged TFS through a carve-out and didn't just sit on it like a lazy trader watching stock tickers race by. Instead, they pushed the envelope with smart...

Continue Reading

Top 5 Most Recently Viewed Articles

Semtech Corporation Faces Legal Challenge: Shareholder Rights Explained

Updated Category News Views 160

Understanding the Current Legal Landscape for Semtech Corporation Semtech Corporation, a notable player in the semiconductor industry, is currently embroiled in a significant class action lawsuit concerning alleged violations of federal securities laws. This legal action has garnered the attention of investors and shareholders alike, prompting them to seek clarity on...

Continue Reading
Thsyu Exchange Launch: Revolutionizing Crypto Trading Ahead

Updated Category News Views 257

Thsyu Exchange Launch: A New Era in Cryptocurrency Trading Thsyu Exchange is excited to unveil its official launch, a pivotal moment in the cryptocurrency trading landscape. With an emphasis on innovation, security, and user empowerment, Thsyu is poised to redefine the way traders engage with digital currencies. By harmonizing robust technology and user-friendly...

Continue Reading
Analyzing AutoZone's Options Market Movements and Trends

Updated Category News Views 168

Understanding AutoZone's Options Activity Recent movements in the options market for AutoZone (AZO) have caught the attention of savvy investors. Notable trends indicate a bullish sentiment prevalent among several key market players, highlighting significant investments in options related to this leading automotive parts retailer. Tracking options activity has brought to...

Continue Reading
Discovering Solana's Prominent Role in Modern Finance

Updated Category News Views 165

Solana's Ascendancy in the Crypto Landscape 21Shares has shed light on Solana's significant growth and development, showcasing it as a formidable player in the blockchain domain. In their latest report, dubbed the 'State of Crypto', 21Shares highlights Solana's emergence as the backbone of next-generation financial solutions. The Power of Solana Blockchain Renowned for...

Continue Reading
AleAnna, Inc. Prepares for Gas Production at Longanesi Field

Updated Category News Views 185

AleAnna, Inc. Prepares for Gas Production at Longanesi Field AleAnna and its partner Societa Energia Padana have cleared all the necessary authorization hurdles to commence production at the Longanesi Field. This project symbolizes a crucial advancement in alleviating Europe’s natural gas deficit. Production will begin promptly once the processing facility stabilizes,...

Continue Reading